Calling all DTM&H Alumni!
Registration's OPEN for LSTM's DTM&H Alumni Weekend (June 7-8)!
Reconnect, hear inspiring talks & delve into the latest advancements! Limited space - register NOW: https://t.co/4KIcpUF1gq
#LSTM125#LSTMAlumi
Massive credit and kudos to @PriyaDPatel5, the diligent dynamo behind this important result, online in the Lancet today. Typhoid Conjugate Vaccines give durable protection for at least 4 years, across all age-groups from 9 months to 12 years old.
https://t.co/C3RpA6lSTF
Our fully-funded, four-year MRC Doctoral Training Partnership (DTP) and iCASE studentships, are open to applicants for an October start.
The deadline for stage 1 applications is Sunday 21st January 2024.
Find out more and apply online: https://t.co/TpF2or1Z9Our fully-funded, four-year MRC Doctoral Training Partnership (DTP) and iCASE studentships, are open to applicants for an October start.
The deadline for stage 1 applications is Sunday 21st January 2024.
Find out more and apply online: https://t.co/TpF2or1Z9Our fully-funded, four-year MRC Doctoral Training Partnership (DTP) and iCASE studentships, are open to applicants for an October start.
The deadline for stage 1 applications is Sunday 21st January 2024.
Find out more and apply online: https://t.co/TpF2or1Z9Our fully-funded, four-year MRC Doctoral Training Partnership (DTP) and iCASE studentships, are open to applicants for an October start.
The deadline for stage 1 applications is Sunday 21st January 2024.
Find out more and apply online: https://t.co/TpF2or1Z9S
Looking for a PhD in Immunology? @DanielaVaccines and I have a fully funded studentship available!
A really exciting opportunity to study trained immunity through controlled human infection - take a look here: https://t.co/wcwMjwHwer
Come and join the team! 🥼🧫🔬🦠
Our fully-funded, four-year MRC Doctoral Training Partnership (DTP) and iCASE studentships, are now open to applicants for an October 2024 start.
The deadline for initial applications is Sunday 21 January 2024.
Find out more and apply online: https://t.co/wqJr4zWEMy
The excitement is building for this evening's #THEAwards! Honoured to be shortlisted for 'University of the Year', an achievement that speaks volumes about our impact as a small, specialist research institution. Wishing luck to the other nominees as we await the big reveal.
We conducted a combined analysis of the now 8 trials that studied the effect of BCG vaccine against COVID-19 and other respiratory infections in health care workers and elderly. BCG was associated with a 39% (3-62%) reduction in all-cause mortality #NSEvac https://t.co/DHePU3KAQQ
Guest editing a Special Issue of @MDPIOpenAccess Vaccines, entitled 'Advances in Oral Vaccine Development'! Please circulate amongst your networks! 🦠🧫💊🔬 https://t.co/uiPUm63zUC
Our fully-funded, 4-year MRC Doctoral Training Partnership and iCASE studentships, available to commence October 2023. #MRCDTP
Find out more about how you can apply here: https://t.co/ZMbanrCpLk
NC3Rs project grant holder @stuains is organising a free online meeting to discuss the current snake venom lethality murine model, and potential improvements/new models.
📅26 January 2023
Register now: https://t.co/QLvkrPtqky
Great turnout and discussions for today's @UK_NPAW#NPAW2022 event at @LSTMnews on traditional academic and alternative career pathways for ECRs. Thank you to all our panelists and chairs (listed below) ☺️
#LovePostdocs
We have a new Dr in the house! - Many congratulations to Dr Emmanuel Moyo for passing his PhD viva with flying colours!!👏👏👏Emanuel's thesis focused on the pharmacology of novel fluroquinolones against TB as well as looking at drug resistance evolution @LSTMnews@CDD_LSTM
Just finally established SARS-CoV-2 live imaging at @LSTMnews. The ultimate tool offering endless possibilities. Exciting times ahead! Watch how these cells turn red when infected 🤯🔴🦠 More awesome videos the come..! #SARSCoV2#COVID19#Microscopy
New, funded #PhD opportunity for a #chemist who would like to develop skills in #microbiology and tackle #AMR; Developing novel metallo-beta-lactamase inhibitors against resistant bacteria @LivUni@LSTMnews
https://t.co/K21xkL6SbZ
Antibody response to the 1st vaccine dose in individuals with pre-existing immunity corresponds to that in naïve individuals after the 2nd dose; those with immunity got significantly more side effects. It seems obvious to drop (at least) the 2nd dose. https://t.co/8hjjLpIMQm